HMGB1 is a crucial mediator of systemic inflammatory response, and observational studies from Brazil have shown that SARS-CoV-2 infection induces the upregulation of HMGB1 in patients with the most severe forms of COVID-19(Coronavirus disease 2019) [34]. The gene discussed is HMGB1; the disease is COVID-19.